{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:01:21Z","timestamp":1788930081987,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.semarthrit.2021.03.015","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T03:47:10Z","timestamp":1617335230000},"page":"565-575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Rheumatoid arthritis and risk of lung cancer: Meta-analysis and Mendelian randomization study"],"prefix":"10.1016","volume":"51","author":[{"given":"Xiangrong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaokai","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caichen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiana","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.semarthrit.2021.03.015_bib0001","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1200\/JCO.2010.32.3683","article-title":"Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials","volume":"29","author":"Claassens","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.03.015_bib0002","article-title":"Jemal. Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.03.015_bib0003","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/annonc\/mds476","volume":"24","author":"Couraud","year":"2013","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.03.015_bib0004","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.30155","article-title":"The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases","volume":"63","author":"Crowson","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.03.015_bib0005","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/art.40574","article-title":"The lung in rheumatoid arthritis: focus on interstitial lung disease","volume":"70","author":"Spagnolo","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.03.015_bib0006","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar2404","article-title":"A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis","volume":"10","author":"Smitten","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2021.03.015_bib0007","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.03.015_bib0008","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jnci\/85.4.307","article-title":"Incidence of cancer among patients with rheumatoid arthritis","volume":"85","author":"Gridley","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.03.015_bib0009","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0959-8049(96)00210-9","article-title":"Rheumatoid arthritis and cancer risk","author":"Mellemkjaer","year":"1996","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.03.015_bib0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","article-title":"Risk of malignancy among patients with rheumatic conditions","volume":"88","author":"Thomas","year":"2000","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.03.015_bib0011","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1136\/ard.2004.033993","article-title":"Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists","volume":"64","author":"Askling","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.03.015_bib0012","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.semarthrit.2007.08.006","article-title":"Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population","volume":"37","author":"Ab\u00e1solo","year":"2008","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.03.015_bib0013","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/art.30134","article-title":"The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan","volume":"63","author":"Chen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.03.015_bib0014","article-title":"Risk of malignant neoplasm in patients with incident rheumatoid arthritis 1980\u20132007 in relation to a comparator cohort: a population-based study","volume":"2016","author":"Raheel","year":"2016","journal-title":"Int J Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.03.015_bib0015","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00296-010-1524-0","article-title":"Incidence of malignancy in Japanese patients with rheumatoid arthritis","volume":"31","author":"Yamada","year":"2011","journal-title":"Rheumatol Int"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.03.015_bib0016","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/1756-185X.13655","article-title":"Incidence and patterns of malignancies in a multi-ethnic cohort of rheumatoid arthritis patients","volume":"22","author":"Lim","year":"2019","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.03.015_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3349\/ymj.2019.60.2.223","article-title":"The Risk of Malignancy in Korean Patients with Rheumatoid Arthritis","volume":"60","author":"Lee","year":"2019","journal-title":"Yonsei Med J"},{"issue":"18","key":"10.1016\/j.semarthrit.2021.03.015_bib0018","doi-asserted-by":"crossref","first-page":"e3540","DOI":"10.1097\/MD.0000000000003540","article-title":"Cancer risk in patients with inflammatory systemic autoimmune rheumatic diseases: a nationwide population-based dynamic cohort study in Taiwan","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.03.015_bib0019","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/art.1780400906","article-title":"Rheumatoid arthritis and the risk of malignancy","volume":"40","author":"Cibere","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.03.015_bib0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0002-9343(85)90246-3","article-title":"Occurrence of malignant neoplasms in the Rochester, Minnesota, rheumatoid arthritis cohort","volume":"78","author":"Katusic","year":"1985","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.03.015_bib0021","first-page":"272","article-title":"Tobacco use and cessation for cancer survivors: an overview for clinicians","volume":"64","author":"Karam-Hage","year":"2014","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.03.015_bib0022","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/annrheumdis-2018-212973","article-title":"Exposure to passive smoking and rheumatoid arthritis risk: results from the Swedish EIRA study","volume":"77","author":"Hedstr\u00f6m","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.03.015_bib0023","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.03.015_bib0024","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrcardio.2017.78","article-title":"Mendelian randomization in cardiometabolic disease: challenges in evaluating causality","volume":"14","author":"Holmes","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"19","key":"10.1016\/j.semarthrit.2021.03.015_bib0025","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.semarthrit.2021.03.015_bib0026","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.03.015_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002036","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology-Nutritional Epidemiology (STROBE-nut): an Extension of the STROBE Statement","volume":"13","author":"Lachat","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.semarthrit.2021.03.015_bib0028","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2014.01.027","article-title":"Diagnosis and classification of rheumatoid arthritis","volume":"48-49","author":"Kourilovitch","year":"2014","journal-title":"J Autoimmun"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.03.015_bib0029","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.03.015_bib0030","first-page":"vi5","article-title":"ACR\/EULAR 2010 rheumatoid arthritis classification criteria","volume":"51","author":"Kay","year":"2012","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.03.015_bib0031","doi-asserted-by":"crossref","first-page":"504","DOI":"10.6004\/jnccn.2017.0050","article-title":"Non-small cell lung cancer, Version 5.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Ettinger","year":"2017","journal-title":"J Natl Compr Cancer Netw"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.03.015_bib0032","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s11606-018-4425-7","article-title":"Empirical comparison of publication bias tests in meta-analysis","volume":"33","author":"Lin","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.03.015_bib0033","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2021.03.015_bib0034","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.03.015_bib0035","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ng.582","article-title":"Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci","volume":"42","author":"Stahl","year":"2010","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.semarthrit.2021.03.015_bib0036","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ng.2462","article-title":"High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis","volume":"44","author":"Eyre","year":"2012","journal-title":"Nat Genet"},{"issue":"7488","key":"10.1016\/j.semarthrit.2021.03.015_bib0037","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.03.015_bib0038","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/art.1780371011","article-title":"A cross-sectional and longitudinal comparison of the Rome criteria for active rheumatoid arthritis (equivalent to the American College of Rheumatology 1958 criteria) and the American College of Rheumatology 1987 criteria for rheumatoid arthritis","volume":"37","author":"Jacobsson","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.03.015_bib0039","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/ije\/dyu005","article-title":"Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome","volume":"43","author":"Burgess","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.03.015_bib0040","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.03.015_bib0041","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/sim.6835","article-title":"Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods","volume":"35","author":"Burgess","year":"2016","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.03.015_bib0042","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ije\/dyv071","article-title":"Mendelian randomization studies: a review of the approaches used and the quality of reporting","volume":"44","author":"Boef","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.03.015_bib0043","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ije\/dyy258","article-title":"Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption","volume":"48","author":"Bowden","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.03.015_bib0044","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.03.015_bib0045","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/s41588-018-0164-2","article-title":"Publisher Correction: Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.03.015_bib0046","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/aje\/126.2.356","article-title":"A simple estimator of minimum detectable relative risk, sample size, or power in cohort studies","volume":"126","author":"Armstrong","year":"1987","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.03.015_bib47","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC201901010","article-title":"Rheumatoid Arthritis","volume":"170","author":"Sparks","year":"2019","journal-title":"Annals of internal medicine"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.03.015_bib0048","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.21037\/jtd.2018.06.62","article-title":"Clinicopathological features of lung cancer in patients with rheumatoid arthritis","volume":"10","author":"Liu","year":"2018","journal-title":"J Thorac Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.03.015_bib0049","doi-asserted-by":"crossref","first-page":"220","DOI":"10.21037\/tlcr.2018.05.06","article-title":"The epidemiology of lung cancer","volume":"7","author":"de Groot","year":"2018","journal-title":"Transl Lung Cancer Res"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.03.015_bib0050","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/ard.2006.063412","article-title":"Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients","volume":"66","author":"van der Pouw Kraan","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2021.03.015_bib0051","doi-asserted-by":"crossref","first-page":"22279","DOI":"10.3390\/ijms151222279","article-title":"Smoking and rheumatoid arthritis","volume":"15","author":"Chang","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.03.015_bib0052","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41584-019-0275-x","article-title":"Mechanisms of lung disease development in rheumatoid arthritis","volume":"15","author":"Wang","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2021.03.015_bib0053","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1136\/ard.2010.142109","article-title":"Prevention of autoimmune rheumatic disease: state of the art and future perspectives","volume":"69","author":"Klareskog","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"45","key":"10.1016\/j.semarthrit.2021.03.015_bib0054","first-page":"1226","article-title":"Smoking-attributable mortality, years of potential life lost, and productivity losses \u2013 United States, 2000-2004","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.03.015_bib0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMsa1211127","article-title":"50-year trends in smoking-related mortality in the United States","volume":"368","author":"Thun","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.semarthrit.2021.03.015_bib0056","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1002\/ijc.27816","article-title":"Lung carcinogenesis by tobacco smoke","volume":"131","author":"Hecht","year":"2012","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.03.015_bib0057","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00408-014-9664-8","article-title":"Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis","volume":"193","author":"Khan","year":"2015","journal-title":"Lung"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.03.015_bib0058","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.21037\/jtd.2018.05.75","article-title":"Lung cancer and interstitial lung disease: a literature review","volume":"10","author":"Naccache","year":"2018","journal-title":"J Thorac Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.03.015_bib0059","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.03.015_bib0060","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics \u2013 a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.03.015_bib0061","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1183\/13993003.00357-2015","article-title":"Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease","volume":"47","author":"Solomon","year":"2016","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.03.015_bib0062","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/blood-2016-04-709584","article-title":"A novel humanized mouse model with significant improvement of class-switched, antigen-specific antibody production","volume":"129","author":"Yu","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.03.015_bib0063","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canlet.2014.08.024","article-title":"The cyclooxygenase-2\/thromboxane A2 pathway: a bridge from rheumatoid arthritis to lung cancer?","volume":"354","author":"Huang","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.semarthrit.2021.03.015_bib0064","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/bs.ai.2015.09.006","article-title":"MAP4K Family Kinases in Immunity and Inflammation","volume":"129","author":"Chuang","year":"2016","journal-title":"Adv Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.03.015_bib0065","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12929-019-0570-5","article-title":"MAP4K3\/GLK in autoimmune disease, cancer and aging","volume":"26","author":"Chuang","year":"2019","journal-title":"J Biomed Sci"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.03.015_bib0066","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1200\/JCO.1997.15.2.499","article-title":"Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients","volume":"15","author":"Warzocha","year":"1997","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.03.015_bib0067","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2007.07.004","article-title":"The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages","volume":"66","author":"Allavena","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.03.015_bib0068","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2217\/fon-2019-0722","article-title":"Molecular mechanisms underlying rheumatoid arthritis and cancer development and treatment","volume":"16","author":"Morand","year":"2020","journal-title":"Future Oncol"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.03.015_bib0069","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/rheumatology\/kes350","article-title":"Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population","volume":"52","author":"Mercer","year":"2013","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.03.015_bib0070","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.lungcan.2007.06.013","article-title":"Lung cancer after exposure to disease modifying anti-rheumatic drugs","volume":"59","author":"Bernatsky","year":"2008","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.03.015_bib0071","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/EDE.0000000000000081","article-title":"Methodological challenges in mendelian randomization","volume":"25","author":"VanderWeele","year":"2014","journal-title":"Epidemiology"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221000469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221000469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:06:15Z","timestamp":1758733575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017221000469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0049017221000469"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.03.015","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatoid arthritis and risk of lung cancer: Meta-analysis and Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}